Cite
HARVARD Citation
Kim, A. et al. (2021). Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration. Clinical and translational science. 14 (2), pp. 635-644. [Online].